Advertisement
Journal of Shoulder and Elbow Surgery

Outpatient total shoulder arthroplasty: a population-based study comparing adverse event and readmission rates to inpatient total shoulder arthroplasty

      Background

      The rate of total shoulder arthroplasty (TSA) is rising, which has an impact on health care expenditure. One avenue to mitigate cost is outpatient TSA. There are currently no published reports of this practice. In this study, we determine the 30-day adverse event and readmission rates after outpatient TSA and compare these rates with inpatient TSA.

      Methods

      A retrospective cohort study using a population database in the United States was undertaken. Patients who underwent primary TSA between 2005 and 2014 were identified and divided into 2 cohorts based on length of stay (LOS): outpatient TSA (LOS 0 days) and inpatient TSA (LOS >0 days). Patient and procedure characteristics were collected. The 30-day adverse event and readmission rates were calculated for each cohort. A multivariate logistic regression determined if the odds of an adverse event or readmission were significantly different between the inpatient and outpatient TSA cohorts.

      Results

      Overall, 7197 patients in this database underwent TSA between 2005 and 2014, of which 173 patients (2.4%) underwent outpatient TSA. The 30-day adverse event rate in the outpatient and inpatient TSA cohorts was 2.31% and 7.89%, respectively. The 30-day readmission rate in the outpatient and inpatient TSA cohorts was 1.74% and 2.93%, respectively. In the multivariate logistic regression, the odds of an adverse event or readmission were not significantly different (odds ratio of 0.4 [P = .077] and odds ratio of 0.7 [P = .623], respectively).

      Conclusion

      There are no significant differences in the 30-day adverse event and readmission rates between outpatient and inpatient TSA. In the appropriately selected patient, outpatient TSA is safe and cost-effective.

      Level of evidence

      Keywords

      To read this article in full you will need to make a payment

      References

        • Anthony C.A.
        • Westermann R.W.
        • Gao Y.
        • Pugely A.J.
        • Wolf B.R.
        • Hettrich C.M.
        What are risk factors for 30-day morbidity and transfusion in total shoulder arthroplasty? A review of 1922 cases.
        Clin Orthop Relat Res. 2015; 473: 2099-2105
        • Aynardi M.
        • Post Z.
        • Ong A.
        • Orozco F.
        • Sukin D.C.
        Outpatient surgery as a means of cost reduction in total hip arthroplasty: a case-control study.
        HSS J. 2014; 10: 252-255
        • Berger R.A.
        • Kusuma S.K.
        • Sanders S.A.
        • Thill E.S.
        • Sporer S.M.
        The feasibility and perioperative complications of outpatient knee arthroplasty.
        Clin Orthop Relat Res. 2009; 467: 1443-1449
        • Berger R.A.
        • Sanders S.A.
        • Thill E.S.
        • Sporer S.M.
        • Della Valle C.
        Newer anesthesia and rehabilitation protocols enable outpatient hip replacement in selected patients.
        Clin Orthop Relat Res. 2009; 467: 1424-1430
        • Bertin K.C.
        Minimally invasive outpatient total hip arthroplasty: a financial analysis.
        Clin Orthop Relat Res. 2005; : 154-163
        • Bohl D.D.
        • Samuel A.M.
        • Basques B.A.
        • Della Valle C.J.
        • Levine B.R.
        • Grauer J.N.
        How much do adverse event rates differ between primary and revision total joint arthroplasty.
        J Arthroplasty. 2016; 31: 596-602
        • Bozic K.J.
        • Ward L.
        • Vail T.P.
        • Maze M.
        Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction.
        Clin Orthop Relat Res. 2014; 472: 188-193
        • Courtney P.M.
        • Rozell J.C.
        • Melnic C.M.
        • Lee G.C.
        Who should not undergo short stay hip and knee arthroplasty? Risk factors associated with major medical complications following primary total joint arthroplasty.
        J Arthroplasty. 2015; 30: 1-4
        • Cross M.B.
        • Berger R.
        Feasibility and safety of performing outpatient unicompartmental knee arthroplasty.
        Int Orthop. 2014; 38: 443-447
        • Cvetanovich G.L.
        • Schairer W.W.
        • Haughom B.D.
        • Nicholson G.P.
        • Romeo A.A.
        Does resident involvement have an impact on postoperative complications after total shoulder arthroplasty? An analysis of 1382 cases.
        J Shoulder Elbow Surg. 2015; 24: 1567-1573
        • Day J.S.
        • Lau E.
        • Ong K.L.
        • Williams G.R.
        • Ramsey M.L.
        • Kurtz S.M.
        Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015.
        J Shoulder Elbow Surg. 2010; 19: 1115-1120
        • D'Alessio J.G.
        • Rosenblum M.
        • Shea K.P.
        • Freitas D.G.
        A retrospective comparison of interscalene block and general anesthesia for ambulatory surgery shoulder arthroscopy.
        Reg Anesth. 1995; 20: 62-68
        • Dunn J.C.
        • Lanzi J.
        • Kusnezov N.
        • Bader J.
        • Waterman B.R.
        • Belmont P.J.
        Predictors of length of stay after elective total shoulder arthroplasty in the United States.
        J Shoulder Elbow Surg. 2015; 24: 754-759
        • Gillespie R.
        • Shishani Y.
        • Joseph S.
        • Streit J.J.
        • Gobezie R.
        Neer Award 2015: a randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty.
        J Shoulder Elbow Surg. 2015; 24: 1679-1684
        • Hartog Y.M.
        • Mathijssen N.M.
        • Vehmeijer S.B.
        Total hip arthroplasty in an outpatient setting in 27 selected patients.
        Acta Orthop. 2015; 86: 667-670
        • Jain N.B.
        • Higgins L.D.
        • Guller U.
        • Pietrobon R.
        • Katz J.N.
        Trends in the epidemiology of total shoulder arthroplasty in the United States from 1990-2000.
        Arthritis Rheum. 2006; 55: 591-597
        • Khuri S.F.
        • Henderson W.G.
        • Daley J.
        • Jonasson O.
        • Jones R.S.
        • Campbell Jr, D.A.
        • et al.
        Successful implementation of the Department of Veterans Affairs' National Surgical Quality Improvement Program in the private sector: the Patient Safety in Surgery study.
        Ann Surg. 2008; 248: 329-336
        • Kort N.P.
        • Bemelmans Y.F.
        • Schotanus M.G.
        Outpatient surgery for unicompartmental knee arthroplasty is effective and safe.
        Knee Surg Sports Traumatol Arthrosc. 2015; (Jul 1; Epub ahead of print)
        • Lovald S.T.
        • Ong K.L.
        • Malkani A.L.
        • Lau E.C.
        • Schmier J.K.
        • Kurtz S.M.
        • et al.
        Complications, mortality, and costs for outpatient and short-stay total knee arthroplasty patients in comparison to standard-stay patients.
        J Arthroplasty. 2014; 29: 510-515
        • Lyman S.
        • Sherman S.
        • Carter T.I.
        • Bach P.B.
        • Mandl L.A.
        • Marx R.G.
        Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty.
        Clin Orthop Relat Res. 2006; 448: 152-156
        • Matsen F.A.
        • Li N.
        • Gao H.
        • Yuan S.
        • Russ S.M.
        • Sampson P.D.
        Factors affecting length of stay, readmission, and revision after shoulder arthroplasty: a population-based study.
        J Bone Joint Surg Am. 2015; 97: 1255-1263
        • Menendez M.E.
        • Baker D.K.
        • Fryberger C.T.
        • Ponce B.A.
        Predictors of extended length of stay after elective shoulder arthroplasty.
        J Shoulder Elbow Surg. 2015; 24: 1527-1533
        • Navarro R.A.
        • Inacio M.C.
        • Burke M.F.
        • Costouros J.G.
        • Yian E.H.
        Risk of thromboembolism in shoulder arthroplasty: effect of implant type and traumatic indication.
        Clin Orthop Relat Res. 2013; 471: 1576-1581
        • Parvizi J.
        • Mui A.
        • Purtill J.J.
        • Sharkey P.F.
        • Hozack W.J.
        • Rothman R.H.
        Total joint arthroplasty: When do fatal or near-fatal complications occur?.
        J Bone Joint Surg Am. 2007; 89: 27-32
        • Rana A.J.
        • Bozic K.J.
        Bundled payments in orthopaedics.
        Clin Orthop Relat Res. 2015; 473: 422-425
        • Singh J.A.
        • Ramachandran R.
        Age-related differences in the use of total shoulder arthroplasty over time: use and outcomes.
        Bone Joint J. 2015; 97-B: 1385-1389
        • Thienpont E.
        • Lavand'homme P.
        • Kehlet H.
        The constraints on day-case total knee arthroplasty: the fastest fast track.
        Bone Joint J. 2015; 97-B: 40-44
      1. User Guide for the 2012 ACS NSQIP Participant Use Data File.
        (Available at:)
        • Waterman B.R.
        • Dunn J.C.
        • Bader J.
        • Urrea L.
        • Schoenfeld A.J.
        • Belmont P.J.
        Thirty-day morbidity and mortality after elective total shoulder arthroplasty: patient-based and surgical risk factors.
        J Shoulder Elbow Surg. 2015; 24: 24-30
        • Yu S.
        • Garvin K.L.
        • Healy W.L.
        • Pellegrini V.D.
        • Iorio R.
        Preventing hospital readmissions and limiting the complications associated with total joint arthroplasty.
        J Am Acad Orthop Surg. 2015; 23: e60-71